NFKB1 and prostate carcinoma: This activation of NF-κB survival signalling is believed to provide a growth advantage in androgen-independent prostate cancer cells by suppressing apoptosis and inducing cell adhesion and angiogenic potential (Huang et al, 2001; Gasparian et al, 2002).